Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 2/26/2013 11:14:38 AM : Underperform Start Price: $6.67 OSIR Score: -30.11

the reward does not outweigh the risk

Featured Broker Partners


Advertisement